Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of EUR 12.56 billion. The enterprise value is 13.34 billion.

Market Cap	12.56B
Enterprise Value	13.34B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.85M
Shares Outstanding	n/a
Shares Change (YoY)	-4.36%
Shares Change (QoQ)	-2.73%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	220.73M

Valuation Ratios

The trailing PE ratio is 24.43 and the forward PE ratio is 15.02.

PE Ratio	24.43
Forward PE	15.02
PS Ratio	3.38
PB Ratio	2.94
P/TBV Ratio	42.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.00, with an EV/FCF ratio of 14.51.

EV / Earnings	25.96
EV / Sales	3.83
EV / EBITDA	12.00
EV / EBIT	16.28
EV / FCF	14.51

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.55.

Current Ratio	3.24
Quick Ratio	2.29
Debt / Equity	0.55
Debt / EBITDA	1.96
Debt / FCF	2.54
Interest Coverage	7.74

Financial Efficiency

Return on equity (ROE) is 11.77% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	11.77%
Return on Assets (ROA)	6.92%
Return on Invested Capital (ROIC)	8.20%
Return on Capital Employed (ROCE)	12.64%
Revenue Per Employee	526,301
Profits Per Employee	72,766
Employee Count	7,063
Asset Turnover	0.47
Inventory Turnover	2.30

Taxes

In the past 12 months, Hologic has paid 115.03 million in taxes.

Income Tax	115.03M
Effective Tax Rate	18.29%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	24

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.41

Income Statement

In the last 12 months, Hologic had revenue of EUR 3.72 billion and earned 513.95 million in profits. Earnings per share was 2.21.

Revenue	3.72B
Gross Profit	2.27B
Operating Income	881.84M
Pretax Income	628.98M
Net Income	513.95M
EBITDA	1.16B
EBIT	881.84M
Earnings Per Share (EPS)	2.21

Full Income Statement

Balance Sheet

The company has 1.50 billion in cash and 2.34 billion in debt, giving a net cash position of -835.77 million.

Cash & Cash Equivalents	1.50B
Total Debt	2.34B
Net Cash	-835.77M
Net Cash Per Share	n/a
Equity (Book Value)	4.26B
Book Value Per Share	19.13
Working Capital	2.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.04 billion and capital expenditures -125.56 million, giving a free cash flow of 919.05 million.

Operating Cash Flow	1.04B
Capital Expenditures	-125.56M
Free Cash Flow	919.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.01%, with operating and profit margins of 23.72% and 13.83%.

Gross Margin	61.01%
Operating Margin	23.72%
Pretax Margin	16.92%
Profit Margin	13.83%
EBITDA Margin	31.10%
EBIT Margin	23.72%
FCF Margin	24.72%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.36%
Shareholder Yield	n/a
Earnings Yield	4.09%
FCF Yield	7.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.29 and a Piotroski F-Score of 7.

Altman Z-Score	4.29
Piotroski F-Score	7